Appili Therapeutics Inc (APLI) — Cash Flow Reinvestment Rate

Latest as of March 2025: 0.00x

Appili Therapeutics Inc (APLI) has a Cash Flow Reinvestment Rate of 0.00x as of March 2025, reinvesting CA$2.36K (capex CA$2.36K ) from operating cash flow of CA$1.03 Million. Explore reinvestment intensity of Appili Therapeutics Inc to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.00x

(Capex + Investments) / Operating CF

Total Reinvested

CA$2.36K

Capex + Investments

Operating Cash Flow

CA$1.03 Million

CAD

Capital Expenditures

CA$2.36K

CAD

Appili Therapeutics Inc Cash Flow Reinvestment Rate (2025–2025)

Historical reinvestment intensity for Appili Therapeutics Inc across 1 annual periods. Also explore Appili Therapeutics Inc assets under control for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Appili Therapeutics Inc (2025–2025)

Year-by-year capital reinvestment analysis for Appili Therapeutics Inc. For live market cap and broader valuation context, see Appili Therapeutics Inc market cap and net worth.

Year	Reinvestment Rate	Total Reinvested (CAD)	Operating CF	Capex	YoY Change
2025	0.01x	CA$4.72K	CA$868.82K	CA$2.36K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow